Skip to main content

Advertisement

Log in

Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

The PRIAMO study is a cross-sectional longitudinal observational study aimed at describing epidemiology and evolution of non-motor symptoms (NMS) in patients with different forms of parkinsonism recruited in 55 Italian centres and evaluated over 24 months. In this paper, we are reporting prevalence and clinical characteristics of NMS in patients with atypical and secondary parkinsonism. Out of 1307 consecutive patients with a diagnosis of parkinsonism, 83 patients had vascular parkinsonism (VP), 34 had multiple system atrophy (MSA), 30 had progressive supranuclear palsy (PSP), 14 had dementia with Lewy bodies (DLB) and 11 had corticobasal degeneration (CBD). MSA and DLB had the highest number of NMS domains and symptoms, respectively. Gastrointestinal symptoms, pain, urinary problems and postural instability due to orthostatic hypotension were most frequent in MSA. Sleep disturbances were also common with a prevalence of approximately 70% in all diagnostic groups but CBD (36%). Psychiatric symptoms and attention and memory impairment were frequently observed in all diagnoses but were most prevalent among DLB patients, whereas the prevalence of skin and respiratory disorders was rather low in all forms, ranging between 10 and 30%. Atypical parkinsonism patients also reported a low QoL, with no significant differences among the different forms, whereas PD and VP patients had a better QoL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Antonini A, Colosimo C, Marconi R, Morgante L, Barone P (2008) The PRIAMO Study: background, methods and recruitment. Neurol Sci 2:61–65

    Article  Google Scholar 

  2. Appollonio I, Leone M, Isella V et al (2005) The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol Sci 26:108–116

    Article  CAS  PubMed  Google Scholar 

  3. Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN (2009) NNIPPS Study Group Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain 132:156–171

    Article  PubMed  Google Scholar 

  4. Chaudhuri KR, Healy DG, Schapira A (2006) Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 5:235–245

    Article  PubMed  Google Scholar 

  5. Colosimo C, Geser F, Benarroch EE, Wenning GK (2007) Multiple system atrophy. In: Gilman S (ed) Neurobiology of disease. Academic Press, CA, pp 200–202

    Google Scholar 

  6. Colosimo C, Tiple D, Berardelli A (2008) Clinical differential diagnosis of parkinsonism. Future Neurol 3:287–298

    Article  Google Scholar 

  7. Dubois B, Slachevsky A, Litvan I et al (2000) The FAB: a Frontal Assessment Battery at bedside. Neurology 55:1621–1626

    CAS  PubMed  Google Scholar 

  8. Fahn S, Elton R, Members of the UPDRS Development Committee (1987) The Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent developments in Parkinson’s disease, vol 2. Macmillan Health Care Information, Florham Park, pp 153–63, 293–304

  9. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-Mental State”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198

    Article  CAS  PubMed  Google Scholar 

  10. Ford B, Louise P, Greene P et al (1996) Oral and genital pain syndromes in Parkinson’s disease. Mov Disord 11:421–426

    Article  CAS  PubMed  Google Scholar 

  11. Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39

    Article  CAS  PubMed  Google Scholar 

  12. Gilman S, Low PA, Quinn N et al (1999) Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 163:94–98

    Article  CAS  PubMed  Google Scholar 

  13. Gilman S, Wenning GK, Low PA et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670–676

    Article  CAS  PubMed  Google Scholar 

  14. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62

    Article  CAS  PubMed  Google Scholar 

  15. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442

    CAS  PubMed  Google Scholar 

  16. Litvan I (2005) Atypical Parkinsonian disorders—clinical and research aspects. Humana Press, Totowa

    Google Scholar 

  17. Litvan I (2007) Update on atypical parkinsonian disorders. Curr Opin Neurol 20:434–437

    Article  CAS  PubMed  Google Scholar 

  18. Litvan I, Agid Y, Calne D et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1–9

    CAS  PubMed  Google Scholar 

  19. Litvan I, Bhatia KP, Burn DJ et al (2003) Movement Disorders Society Scientific Issues Committee report: SIC task force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18:467–486

    Article  PubMed  Google Scholar 

  20. Litvan I, Campbell G, Mangone CA et al (1997) Which clinical features differentiate progressive supranuclear palsy from related disorders? A clinicopathological study. Brain 12:65–74

    Article  Google Scholar 

  21. Mamikonyan E, Moberg PJ, Siderowf A, Duda JE, Have TT, Hurtig HI, Stern MB, Weintraub D (2009) Mild cognitive impairment is common in Parkinson’s disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism Relat Disord 15:226–231

    Article  PubMed  Google Scholar 

  22. McDowell I, Newell C (1996) Measuring health: a guide to rating scales and questionnaires. Oxford University Press, New York

    Google Scholar 

  23. McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the LBD consortium. Neurology 65:1863–1872

    Article  CAS  PubMed  Google Scholar 

  24. McKeith I, Mintzer J, Aarsland D et al (2004) Dementia with Lewy bodies. Lancet Neurol 3:19–28

    Article  PubMed  Google Scholar 

  25. Measso GF, Cavarzeran F, Zappalà G et al (1993) The Mini-Mental State Examination: normative study of a random sample of Italian population. Dev Neuropsychol 9:77–85

    Article  Google Scholar 

  26. Morgante L, Rocca WA, Di Rosa AE et al (1992) Prevalence of Parkinson’s disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. The Sicilian Neuro-Epidemiologic Study (SNES) Group. Neurology 42:1901–1907

    CAS  PubMed  Google Scholar 

  27. Müller J, Wenning GK, Jellinger K, McKee A, Poewe W, Litvan I (2000) Progression of Hoehn and Yahr stages in Parkinsonian disorders: a clinicopathologic study. Neurology 55:888–891

    PubMed  Google Scholar 

  28. Peto V, Jenkinson C, Fitzpatrick R et al (1995) The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res 4:241–248

    Article  CAS  PubMed  Google Scholar 

  29. Quinn N, Koller WC, Lang AE et al (1996) Painful Parkinson’s disease. Lancet 1:1366–1369

    Google Scholar 

  30. Riley DE, Lang AE (2000) Clinical diagnostic criteria of corticobasal degeneration. Adv Neurol 82:1233–1245

    Google Scholar 

  31. Stamelou M, Reuss A, Pilatus U et al (2008) Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial. Mov Disord 23:942–949

    Article  PubMed  Google Scholar 

  32. Tison F, Wenning GK, Volonte MA et al (1996) Pain in multiple system atrophy. J Neurol 243:153–156

    Article  CAS  PubMed  Google Scholar 

  33. Tuite PJ, Krawczewski K (2007) Parkinsonism: a review-of-system approach to diagnosis. Semin Neurol 27:113–122

    Article  PubMed  Google Scholar 

  34. Wenning GK, Colosimo C, Geser F, Poewe W (2004) Multiple system atrophy. Lancet Neurol 3:93–103

    Article  PubMed  Google Scholar 

  35. Williams DR, Lees AJ (2009) Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 8:270–279

    Article  PubMed  Google Scholar 

  36. Zijlmans JC, Daniel SE, Hughes AJ, Révész T, Lees AJ (2004) Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 19:630–640

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by an educational grant issued by Boehringer-Ingelheim, Italy. L. Simoni is an employee of Medidata s.r.l.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Carlo Colosimo.

Additional information

The members of the PRIAMO study group are listed in Appendix 1.

Appendix I: The PRIAMO study group

Appendix I: The PRIAMO study group

Steering Committee:

  • Angelo Antonini—Istituti Clinici di Perfezionamento, Milano,

  • Paolo Barone—Università Federico II, Napoli,

  • Carlo Colosimo—Sapienza Università di Roma,

  • Roberto Marconi—Ospedale della Misericordia, Grosseto,

  • Letterio Morgante—Università di Messina, Italy.

Participating centres:

  • Benincasa D—Ospedale Sant’Andrea, Sapienza Università di Roma

  • Biguzzi S—Ospedale Sant’Anna, Ferrara,

  • Braga M—Ospedale Civile, Vimercate,

  • Capecci M—Ospedale Umberto I, Ancona;

  • Caravona N—Sapienza Università di Roma,

  • D’Asta G—PO Guzzardi, Vittoria,

  • De Falco FA—Ospedale S Maria Loreto Nuovo, Napoli,

  • De Gaspari D, Pezzoli G—Parkinson Institute, Istituti Clinici di Perfezionamento, Milano,

  • Di Giovanni M, Ospedale Regionale, Aosta;

  • Floris G, Clinica Neurologica, Policlinico Universitario, Monserrato,Cagliari;

  • Gallerini S, Grasso L—Ospedale della Misericordia, Grosseto,

  • Gurgone G—Azienda Ospedaliera S. Giovanni di Dio, Agrigento,

  • Kiferle L, Ospedale Santa Chiara, Pisa;

  • Meoni S—Clinica Neurologica I, Azienda Ospedaliera Universitaria, Firenze

  • Morgante F, Savica R—Università di Messina,

  • Moschella V—Policlinico Tor Vergata, Roma,

  • Pepe F—Fondazione Poliambulanza, Brescia,

  • Petretta V—AORN San Giuseppe Moscati, Avellino,

  • Randisi MG—Azienda Ospedaliera S Elia, Caltanissetta,

  • Romeno M—Ospedale Villa Sofia CTO, Palermo,

  • Santangelo G, Ianniciello M—Università Federico II, Napoli,

  • Sorbello V—Policlinico Universitario, Catania,

  • Fabbrini G, Berardelli A—Sapienza Università di Roma

  • Guidubaldi A—Università Cattolica S Cuore, Roma,

  • Muoio R—IRCCS San Raffaele, Roma,

  • Toni V—PO F Ferrari, Casarano,

  • Logi C—Ospedale Versilia, Camaiore,

  • Ciacci G, Ulivelli M—Policlinico Le Scotte, Siena,

  • Perini M, Lanfranchi S—Ospedale S Antonio Abate, Gallarate,

  • Griffini S, Troianiello B—Istituto Clinico Città di Brescia,

  • Baratti M, Amidei S—Ospedale Ramazzini, Carpi,

  • Consoli D, Iellamo M—Ospedale G Iazzolino, Vibo Valentia,

  • Cuomo T—Ospedale Civile Umberto I, Nocera Inferiore,

  • Scaglioni A, Medici D—Ospedale di Vaio, Fidenza,

  • Abbruzzese G, Di Brigida G—Università degli Studi di Genova, Genova,

  • Cocco GA, Agnetti V—Università degli Studi di Sassari, Sassari,

  • Cossu G, Deriu M—Azienda Ospedaliera G Brotzu, Cagliari,

  • Abrignani M, Modica C—Ospedale San Biagio di Marsala, Marsala,

  • Albani G, Milan E—Istituto Scientifico San Giuseppe, Piancavallo,

  • Martinelli P, Scaglione C—Università di Bologna, Bologna,

  • Mucchiut M, Zanini S—Policlinico Universitario, Udine,

  • Pennisi F—Ospedale di Castelvetrano, Castelvetrano, Trapani,

  • Soliveri P, Albanese A—Istituto Nazionale Neurologico C Besta, Milano,

  • Bartolomei L, L’erario R—Ospedale Civile San Bortolo, Vicenza,

  • Capus L, Ferigo L—Ospedale di Gattinara, Trieste,

  • Marano R, Nastasi V—Azienda Ospedaliera Papardo, Messina,

  • Luciano R, Maiello L—Ospedale Monaldi, Napoli,

  • Simone P, Fogli D—Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo,

  • Lopiano L, Pesare M—ASO Molinette, Torino,

  • Nordera G, Pilleri E—Casa di Cura Villa Margherita, Arcugnano,

  • Scaravilli T—Azienda Ospedaliera Padova, Padova,

  • Giaccaglini E, Alesi C—Ospedale Civile, Jesi, Italy.

Sponsorship:

  • Tania Corbetta, Arina Dumitriu, Boehringer Ingelheim, Milano, Italy.

Project Management, Statistical Analyses and data management:

  • Simona Sgarbi, project leader MediData Studi e Ricerche, Modena

  • Andrea Rapisarda, clinical project manager MediData Studi e Ricerche, Modena

  • Sara Rizzoli, Lucia Simoni, statisticians MediData Studi e Ricerche, Modena

  • Luca Zanoli, clinical data manager MediData Studi e Ricerche, Modena

  • Alessandra Manfredi, clinical operation specialist MediData Studi e Ricerche, Modena, Italy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Colosimo, C., Morgante, L., Antonini, A. et al. Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. J Neurol 257, 5–14 (2010). https://doi.org/10.1007/s00415-009-5255-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-009-5255-7

Keywords

Navigation